SGLT2 Inhibitors Enhance Metallothionein Expression in Kidney Proximal Tubules of Adolescents With Type 2 Diabetes

被引：0

作者：

Alakwaa, Fadhl ^{[1
]}

McCown, Phillip J. ^{[1
]}

Naik, Abhijit S. ^{[1
]}

Schaub, Jennifer A. ^{[1
]}

Menon, Rajasree ^{[1
]}

Otto, Edgar A. ^{[1
]}

Nair, Viji ^{[1
]}

Eddy, Sean ^{[1
]}

Pyle, Laura ^{[4
]}

Harned, Roger K. ^{[4
]}

Ladd, Patricia E. ^{[4
]}

Eichinger, Felix H. ^{[1
]}

Fermin, Damian ^{[1
]}

Ju, Wenjun ^{[1
]}

Hodgin, Jeffrey B. ^{[1
]}

Nelson, Robert G. ^{[3
]}

Brosius, Frank C. ^{[2
]}

Kretzler, Matthias ^{[1
]}

Bjornstad, Petter ^{[4
]}

机构：

[1] Univ Michigan, Ann Arbor, MI 48109 USA

[2] Univ Arizona, Tucson, AZ USA

[3] NIDDK, Phoenix, AZ USA

[4] Univ Colorado, Sch Med, Aurora, CO USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

TH-PO211

引用

页码：107 / 107

页数：1

共 50 条

[41] Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
Kelly, Michael S.
Lewis, Jelena
Huntsberry, Ashley M.
Dea, Lauren
Portillo, Ivan
POSTGRADUATE MEDICINE, 2019, 131 (01) : 31 - 42
[42] Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
Evans, Marc
Hicks, Debbie
Patel, Dipesh
Patel, Vinod
McEwan, Phil
Dashora, Umesh
DIABETES THERAPY, 2020, 11 (01) : 37 - 52
[43] SGLT2 inhibitors and renal complications in type 1 diabetes
Petrie, John R.
LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10): : 803 - 805
[44] Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
Marc Evans
Debbie Hicks
Dipesh Patel
Vinod Patel
Phil McEwan
Umesh Dashora
Diabetes Therapy, 2020, 11 : 37 - 52
[45] Type 2 Diabetes: SGLT2 Inhibitors and DPP4 Inhibitors in Comparison
Simon, Annika
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (16) : 1002 - 1002
[46] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
Singhal, Rohit
Hechanova, Lisa Aimee
CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 183 - 189
[47] SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes
Griffin, Tomas P.
Dinneen, Sean F.
ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : JC40 - JC40
[48] SGLT2 Inhibitors: Effect on Myocardial Infarction and Stroke in Type 2 Diabetes
Mukhopadhyay, Pradip
Sanyal, Debmalya
Chatterjee, Purushottam
Pandit, Kaushik
Ghosh, Sujoy
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (08): : 2134 - 2140
[49] SGLT2 inhibitors race to enter type-2 diabetes market
Sheridan, Cormac
NATURE BIOTECHNOLOGY, 2012, 30 (10) : 899 - 900
[50] Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
Beatrice C. Lupsa
Silvio E. Inzucchi
Diabetologia, 2018, 61 : 2118 - 2125

← 1 2 3 4 5 →